Charles J Homcy

Charles J Homcy has an estimated net worth of $111 Million. This is based on reported shares across multiple companies, which include Population Health Investment Co., Inc., KOSAN BIOSCIENCES INC, PLIANT THERAPEUTICS, INC., GERON CORP, BridgeBio Pharma, Inc., Global Blood Therapeutics, Inc., CYTOKINETICS INC, MyoKardia Inc, CEPHALON INC, PORTOLA PHARMACEUTICALS INC, MILLENNIUM PHARMACEUTICALS INC, and Maze Therapeutics, Inc..

2007 was Charles J Homcy's most active year for acquiring shares with 15 total transactions. Charles J Homcy's most active month to acquire stocks was the month of April. 2008 was Charles J Homcy's most active year for disposing of shares, totalling 25 transactions. Charles J Homcy's most active month to dispose stocks was the month of April. 2021 saw Charles J Homcy paying a total of $10,781,250.00 for 151,838 shares, this is the most they've acquired in one year. In 2025 Charles J Homcy cashed out on 662,119 shares for a total of $13,912,442.76, their largest year based on trade value.